PL3244903T3 - Preparat zawierający lactobacillus reuteri i cytrynian do zastosowań medycznych - Google Patents
Preparat zawierający lactobacillus reuteri i cytrynian do zastosowań medycznychInfo
- Publication number
- PL3244903T3 PL3244903T3 PL16700501.6T PL16700501T PL3244903T3 PL 3244903 T3 PL3244903 T3 PL 3244903T3 PL 16700501 T PL16700501 T PL 16700501T PL 3244903 T3 PL3244903 T3 PL 3244903T3
- Authority
- PL
- Poland
- Prior art keywords
- citrate
- preparation
- medical use
- lactobacillus reuteri
- reuteri
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562103201P | 2015-01-14 | 2015-01-14 | |
| PCT/EP2016/050694 WO2016113363A1 (en) | 2015-01-14 | 2016-01-14 | A method of activating lactic acid bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3244903T3 true PL3244903T3 (pl) | 2023-08-14 |
Family
ID=55129894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16700501.6T PL3244903T3 (pl) | 2015-01-14 | 2016-01-14 | Preparat zawierający lactobacillus reuteri i cytrynian do zastosowań medycznych |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12171793B2 (pl) |
| EP (1) | EP3244903B1 (pl) |
| JP (1) | JP6837442B2 (pl) |
| CN (1) | CN107427461B (pl) |
| AU (1) | AU2016208007B2 (pl) |
| BR (1) | BR112017014192B1 (pl) |
| CA (1) | CA2972963C (pl) |
| CL (1) | CL2017001722A1 (pl) |
| CY (1) | CY1126127T1 (pl) |
| ES (1) | ES2952585T3 (pl) |
| HR (1) | HRP20230639T1 (pl) |
| HU (1) | HUE062482T2 (pl) |
| MX (1) | MX385961B (pl) |
| PL (1) | PL3244903T3 (pl) |
| RS (1) | RS64392B1 (pl) |
| SM (1) | SMT202300225T1 (pl) |
| WO (1) | WO2016113363A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11357803B2 (en) | 2017-09-22 | 2022-06-14 | Iowa State University Research Foundation, Inc. | Probiotic compositions for production of dopamine |
| WO2020004933A1 (ko) * | 2018-06-26 | 2020-01-02 | 씨제이제일제당 (주) | 구연산염을 포함하는 유산균 동결 보호용 조성물 |
| CN110320840B (zh) * | 2019-07-11 | 2021-06-22 | 四川长虹网络科技有限责任公司 | 一种可降低物联网产品电池电量消耗的方法及系统 |
| BR112022014252A2 (pt) * | 2020-01-23 | 2022-09-20 | Gervais Danone Sa | Processo para a preparação de uma composição fermentada à base de plantas, composição à base de plantas e composição fermentada à base de plantas |
| EP4056053A1 (en) * | 2021-03-12 | 2022-09-14 | Biogaia AB | Pre-conditioning of l. reuteri |
| US12350300B2 (en) | 2021-10-08 | 2025-07-08 | Iowa State University Research Foundation, Inc. | Use of dopamine producing products to increase vaccine efficacy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3436581B2 (ja) | 1994-03-18 | 2003-08-11 | 雪印乳業株式会社 | 乳糖分解酵素活性の高い菌体の製造法 |
| US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
| US20030017192A1 (en) * | 2001-06-19 | 2003-01-23 | Hanny Kanafani | Process for producing extended shelf-life ready-to-use milk compositions containing probiotics |
| JP3957132B2 (ja) * | 2001-09-07 | 2007-08-15 | キッコーマン株式会社 | 低濁性醤油乳酸菌の分離用培地、同培地を用いる低濁性醤油乳酸菌の分離法及び同乳酸菌を用いる清澄度の高い醤油の製造法 |
| FR2859217B1 (fr) | 2003-09-03 | 2005-11-11 | Rhodia Chimie Sa | Activateur pour ferment a base de bacteries lactiques et procede de preparation d'un produit mettant en oeuvre ledit activateur |
| JP2007330157A (ja) * | 2006-06-15 | 2007-12-27 | Obihiro Univ Of Agriculture & Veterinary Medicine | 乳酸菌及び乳酸菌由来物の癌細胞増殖抑制作用および炎症性サイトカイン抑制作用を測定する方法 |
| US8617537B2 (en) * | 2008-06-10 | 2013-12-31 | Biogaia Ab | Controlled activation of the reuterin-production machinery of lactobacillus |
| FR2967070B1 (fr) * | 2010-11-05 | 2013-07-05 | Oreal | Acide gras monoinsature pour prevenir et/ou traiter les imperfections du teint de la peau |
| US9094785B2 (en) * | 2010-07-16 | 2015-07-28 | Blackberry Limited | Application programming interface for mapping application |
| SG191798A1 (en) * | 2010-12-31 | 2013-08-30 | Abbott Lab | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
| JP5622110B2 (ja) * | 2011-02-21 | 2014-11-12 | 株式会社農 | 新規乳酸菌 |
| JP6051112B2 (ja) | 2013-06-05 | 2016-12-27 | 公立大学法人大阪府立大学 | 白金族金属の回収方法 |
| CN104206539A (zh) * | 2014-08-14 | 2014-12-17 | 澳优乳业(中国)有限公司 | 一种益生菌婴幼儿奶粉 |
-
2016
- 2016-01-14 HU HUE16700501A patent/HUE062482T2/hu unknown
- 2016-01-14 PL PL16700501.6T patent/PL3244903T3/pl unknown
- 2016-01-14 AU AU2016208007A patent/AU2016208007B2/en active Active
- 2016-01-14 JP JP2017555837A patent/JP6837442B2/ja active Active
- 2016-01-14 CA CA2972963A patent/CA2972963C/en active Active
- 2016-01-14 SM SM20230225T patent/SMT202300225T1/it unknown
- 2016-01-14 WO PCT/EP2016/050694 patent/WO2016113363A1/en not_active Ceased
- 2016-01-14 BR BR112017014192-2A patent/BR112017014192B1/pt active IP Right Grant
- 2016-01-14 EP EP16700501.6A patent/EP3244903B1/en active Active
- 2016-01-14 HR HRP20230639TT patent/HRP20230639T1/hr unknown
- 2016-01-14 CN CN201680005682.2A patent/CN107427461B/zh active Active
- 2016-01-14 MX MX2017009247A patent/MX385961B/es unknown
- 2016-01-14 US US15/320,996 patent/US12171793B2/en active Active
- 2016-01-14 ES ES16700501T patent/ES2952585T3/es active Active
- 2016-01-14 RS RS20230608A patent/RS64392B1/sr unknown
-
2017
- 2017-06-28 CL CL2017001722A patent/CL2017001722A1/es unknown
-
2023
- 2023-07-11 CY CY20231100325T patent/CY1126127T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX385961B (es) | 2025-03-18 |
| HK1247561A1 (zh) | 2018-09-28 |
| RS64392B1 (sr) | 2023-08-31 |
| JP2018503684A (ja) | 2018-02-08 |
| HRP20230639T1 (hr) | 2023-09-29 |
| CA2972963C (en) | 2023-03-14 |
| EP3244903B1 (en) | 2023-06-07 |
| BR112017014192A2 (pt) | 2018-03-06 |
| JP6837442B2 (ja) | 2021-03-03 |
| ES2952585T3 (es) | 2023-11-02 |
| CN107427461B (zh) | 2021-04-13 |
| CN107427461A (zh) | 2017-12-01 |
| BR112017014192B1 (pt) | 2022-02-01 |
| WO2016113363A1 (en) | 2016-07-21 |
| CY1126127T1 (el) | 2023-11-15 |
| CA2972963A1 (en) | 2016-07-21 |
| AU2016208007A1 (en) | 2017-07-06 |
| AU2016208007B2 (en) | 2021-09-09 |
| HUE062482T2 (hu) | 2023-11-28 |
| US12171793B2 (en) | 2024-12-24 |
| SMT202300225T1 (it) | 2023-09-06 |
| EP3244903A1 (en) | 2017-11-22 |
| EP3244903C0 (en) | 2023-06-07 |
| MX2017009247A (es) | 2017-10-12 |
| CL2017001722A1 (es) | 2018-04-06 |
| US20170304376A1 (en) | 2017-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3546457T (pt) | Derivado de pirazolo-heteroarílico, método de preparação e a utilização médica do mesmo | |
| GB2542966B (en) | Patient interface and component parts | |
| SG10202002593SA (en) | Activated bifidobacteria and methods of use thereof | |
| IL259711A (en) | Methods for the preparation of protein kinase inhibitors and their medical use | |
| SG11201707816PA (en) | Patient interface and aspects thereof | |
| EP3133914A4 (en) | Continuous cooker stretcher and methods of use thereof | |
| SG10202010420TA (en) | Patient interface and aspects thereof | |
| IL283335B (en) | Dihydropyrimidine-2-one compounds and their medical use | |
| SMT202500469T1 (it) | Combinazione farmaceutica comprendente ponesimod e suo utilizzo nel trattamento della sclerosi multipla | |
| SMT202300225T1 (it) | Preparazione comprendente lactobacillus reuteri e citrato per uso medico | |
| GB201709840D0 (en) | Methods and medical uses | |
| EP3123176A4 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| SG11201802754XA (en) | Blood preparation and profiling | |
| ZA201801134B (en) | Hydroxytriazine compound and medical use thereof | |
| PT3129398T (pt) | Novos agentes médicos e usos dos mesmos | |
| GB201404044D0 (en) | Composition and use of lactobacillus reuteri gmnl-89 in treating type 2 diabetes | |
| GB201502240D0 (en) | Composition and use of lactobacillus reuteri GMNL-263 in decreasing blood lipid levels | |
| PL3302473T3 (pl) | Wytwarzanie cytrynianu sufentanylu i zasady sufentanylu | |
| EP3207856A4 (en) | Connection structure and medical apparatus | |
| GB201709837D0 (en) | Methods and medical uses | |
| IL251930B (en) | Benzylhydroxy derivatives, their preparation and medical uses | |
| ZAA201501678S (en) | Paediatric hospital bed | |
| ZAA201501680S (en) | Paediatric hospital bed | |
| ZAF201600610S (en) | Paediatric hospital bed | |
| ZAF201600608S (en) | Paediatric hospital bed |